Welcome to the world of immunohistochemistry!
📞 800-8581156 📧 info@naim.com.cn
Menu
  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Close
分类
  • Consultation and Feedback
  • Hotspot Focus
  • Immunohistochemistry and Pathology
  • Immunohistochemistry Technology Exchange
  • Industry News
  • Maxxin Dynamics
  • Meeting Notice
  • News and Information
  • Public laboratory
  • Recommended List and Introduction of Newly Developed IHC
  • Service and Support
  • Uncategorized
Product Search
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Rare Types of Esophageal Adenocarcinoma

Introduction:The most common pathological type of esophageal cancer is squamous cell carcinoma, while adenocarcinoma is relatively rare...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

The “Bottom Line” of Pathology

Introduction:There are some sayings circulating in the world that emphasize the importance of pathology, such as: "Pathology is the fou...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Week 18 of “Mai Mai” Pathology Reading Notes | Immunohistochemical Markers for Diagnosis of Kidney and Urinary Tract Tumors (Part 2)

Preface:In the previous issue, we mentioned the use of immunohistochemical methodsforkidney and urinary tracttumors is very necessary f...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Application of CK7 and CK20 Immunohistochemical Staining Patterns in Carcinoma of Unknown Primary

Introduction:Determining the primary origin of tumors is crucial for prognosis and treatment, especially for new targeted therapies. IH...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Fearless Hp Can Also Transform, Did You Know?

Introduction:When it comes to Helicobacter pylori (Hp), it seems that everyone has some understanding of it, because it is the direct c...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Ki-67: Prospects, Potential, and Challenges in Breast Cancer (Part 2)

Introduction:In the previous series of posts, we introducedthe concept and discovery of Ki-67, its role as a prognostic biomarker in br...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Superior Choice for GIST Diagnosis: DOG1 Antibody Maixin Clone “MX067”

Preface:Gastrointestinal stromal tumor (GIST) is the most common mesenchymal tumor of the gastrointestinal tract. Its diagnosis primari...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

The 19th Issue of “Mai Mai” Pathology Weekly Reading Notes | Immunohistochemical Markers for Diagnosis of Prostate and Seminal Vesicle Tumors

Preface: In male reproductive system tumors, tumors of the seminal vesicle and prostate exhibit significant heterogeneity, making ...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Pathology Weekly Reading Notes by “Mai Mai” | Issue 1

Preface:In the world of pathology, one phrase that pathologists frequently encounter is, 'Let's do immunohistochemistry...'Indeed, if p...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Immunohistochemical Antibody Selection Scheme for Spleen Diseases (Part 1)

Introduction:Currently, immunohistochemistry has become a routine tool in pathological differential diagnosis, but the interpretation o...
Continue reading
  • «
  • ‹
  • 5
  • 6
  • 7
  • 8
  • 9
  • ›
  • »

Copyright © 1993 - 2017 Fuzhou Maixin Biotechnology Development Co., Ltd. MinICP No. 05015562-1 | (Fujian) - Non-commercial - 2017-0010

  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Sidebar